athenahealth, Inc (ATHN) Stake Lowered by Macquarie Group Ltd.
Macquarie Group Ltd. decreased its holdings in shares of athenahealth, Inc (NASDAQ:ATHN) by 49.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 58,563 shares of the health services provider’s stock after selling 58,178 shares during the quarter. Macquarie Group Ltd.’s holdings in athenahealth were worth $9,320,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also modified their holdings of ATHN. Summit Trail Advisors LLC boosted its stake in athenahealth by 13,481.3% in the first quarter. Summit Trail Advisors LLC now owns 103,218 shares of the health services provider’s stock worth $103,000 after buying an additional 102,458 shares in the last quarter. Integrated Investment Consultants LLC purchased a new stake in athenahealth in the second quarter worth approximately $150,000. We Are One Seven LLC boosted its stake in athenahealth by 239.2% in the first quarter. We Are One Seven LLC now owns 1,116 shares of the health services provider’s stock worth $160,000 after buying an additional 787 shares in the last quarter. Flinton Capital Management LLC boosted its stake in athenahealth by 62.2% in the first quarter. Flinton Capital Management LLC now owns 1,168 shares of the health services provider’s stock worth $167,000 after buying an additional 448 shares in the last quarter. Finally, Cerebellum GP LLC purchased a new stake in athenahealth in the second quarter worth approximately $176,000.
Shares of ATHN stock opened at $136.60 on Monday. The company has a quick ratio of 2.62, a current ratio of 2.62 and a debt-to-equity ratio of 0.23. athenahealth, Inc has a fifty-two week low of $111.61 and a fifty-two week high of $163.94. The company has a market capitalization of $5.53 billion, a price-to-earnings ratio of 42.96, a P/E/G ratio of 2.41 and a beta of 0.95.
ATHN has been the subject of several research reports. BidaskClub lowered athenahealth from a “sell” rating to a “strong sell” rating in a research note on Friday, August 10th. Oppenheimer upped their target price on athenahealth from $158.00 to $179.00 and gave the stock an “outperform” rating in a research note on Tuesday, June 12th. Canaccord Genuity upped their target price on athenahealth from $125.00 to $160.00 and gave the stock a “hold” rating in a research note on Tuesday, July 31st. Stifel Nicolaus reaffirmed a “hold” rating and issued a $140.00 target price (up previously from $134.00) on shares of athenahealth in a research note on Tuesday, July 31st. Finally, Piper Jaffray Companies upped their target price on athenahealth from $155.00 to $179.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 6th. One analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and seven have issued a buy rating to the company. athenahealth presently has an average rating of “Hold” and a consensus price target of $154.57.
athenahealth Company Profile
athenahealth, Inc, together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services.
Recommended Story: How to Invest in Marijuana Stocks
Want to see what other hedge funds are holding ATHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for athenahealth, Inc (NASDAQ:ATHN).
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.